Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check10 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check46 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check61 days agoChange DetectedThe website has added new features for data download options, while several key government health-related links have been removed.SummaryDifference14%
- Check68 days agoChange DetectedNew resources have been added, including links to major health and government websites such as HHS, NIH, NLM, NCBI, and USA.gov.SummaryDifference0.7%
Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.